State Street Corp lowered its position in shares of MetLife, Inc. (NYSE:MET - Free Report) by 0.1% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 26,731,729 shares of the financial services provider's stock after selling 14,178 shares during the quarter. State Street Corp owned about 3.86% of MetLife worth $2,204,833,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Dimensional Fund Advisors LP lifted its stake in shares of MetLife by 22.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider's stock valued at $378,799,000 after purchasing an additional 988,666 shares during the period. Legal & General Group Plc lifted its stake in shares of MetLife by 5.4% in the 2nd quarter. Legal & General Group Plc now owns 5,299,800 shares of the financial services provider's stock valued at $371,993,000 after purchasing an additional 269,246 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of MetLife by 1.5% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider's stock valued at $375,179,000 after purchasing an additional 68,579 shares during the period. Envestnet Asset Management Inc. increased its holdings in MetLife by 3.2% in the 2nd quarter. Envestnet Asset Management Inc. now owns 3,224,930 shares of the financial services provider's stock worth $226,358,000 after acquiring an additional 100,782 shares in the last quarter. Finally, Stifel Financial Corp increased its holdings in MetLife by 5.0% in the 3rd quarter. Stifel Financial Corp now owns 2,239,841 shares of the financial services provider's stock worth $184,744,000 after acquiring an additional 105,762 shares in the last quarter. Institutional investors and hedge funds own 89.81% of the company's stock.
Analysts Set New Price Targets
Several equities research analysts recently commented on MET shares. Wells Fargo & Company boosted their price target on shares of MetLife from $92.00 to $93.00 and gave the stock an "overweight" rating in a report on Tuesday, November 5th. Piper Sandler upped their target price on shares of MetLife from $85.00 to $92.00 and gave the stock an "overweight" rating in a report on Wednesday, October 2nd. TD Cowen upped their target price on shares of MetLife from $97.00 to $99.00 and gave the stock a "buy" rating in a report on Wednesday, November 27th. Jefferies Financial Group upped their target price on shares of MetLife from $89.00 to $95.00 and gave the stock a "buy" rating in a report on Friday, September 27th. Finally, Morgan Stanley dropped their target price on shares of MetLife from $86.00 to $85.00 and set an "overweight" rating for the company in a report on Monday, August 19th. Fourteen investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the company has an average rating of "Buy" and an average target price of $88.62.
Get Our Latest Analysis on MetLife
MetLife Trading Down 0.3 %
NYSE MET traded down $0.30 during trading hours on Friday, reaching $85.58. The company had a trading volume of 446,809 shares, compared to its average volume of 3,296,370. The stock has a 50-day moving average of $83.73 and a 200 day moving average of $76.91. MetLife, Inc. has a 1-year low of $63.19 and a 1-year high of $89.05. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $59.26 billion, a P/E ratio of 17.26, a price-to-earnings-growth ratio of 0.79 and a beta of 1.06.
MetLife Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Tuesday, November 5th will be given a $0.545 dividend. The ex-dividend date is Tuesday, November 5th. This represents a $2.18 dividend on an annualized basis and a yield of 2.55%. MetLife's payout ratio is currently 43.95%.
MetLife Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.